EagleBio/MutaGEL醛缩酶B PCR检测/200µL/KE09013

价格
¥15500.00
货号:KE09013
浏览量:127
品牌:EagleBio
服务
全国联保
正品保证
正规发票
签订合同
商品描述

MutaGEL® Aldolase B PCR Assay Kit

MutaGEL Aldolase B PCR Assay manufactured in Germany by Immundiagnostik

Size: 24 Samples
Method: PCR (allel specific)
Sample Type: DNA (e.g.whole blood, cheek swab)
Sample Size: 200 µL
For Research Use Only
Controls Included


Storage and Stability:
Store at ≤ -18°C. The kit MutaGEL Aldolase B PCR Assay reagents are stable in the unopened micro tubes until the expiration date indicated (see print on the package). Do not thaw out the content of the “positive control DNA” for more than two times. If necessary, make suitable aliquots. Before use: Spin tubes briefly before opening (contents may become dispersed during shipment).


Assay Background

The liver isoenzyme Aldolase B is critical for sugar metabolism, and a catalytic deficiency due to mutations in its gene may result in hereditary fructose intolerance (HFI) syndrome, with hypoglycaemia and severe abdominal symptoms.
The autosomal recessive disorder HFI is a potentially lethal inborn error in metabolism and the disease poses diagnostic problems because of in part very unspecific clinical manifestations. The present aldolase B PCR test is useful for the detection of the three most common mutations critical for gluconeogenesis and fructose metabolism: A149P (60%), A174D (11%) and N334K (8%). These mutations may account together for more than 80% of all known mutations causing HFI and their screening will be helpful for suited therapy of afflicted patients.
The G>C mutation at bp position 448 results in an amino acid exchange (from alanine to praline) at position 150 (earlier 149). Frequency of that mutation is 1:250 in Caucasians and disease by homozygous presence of C-allele is about 1:50000 (=0.002%).


Related Products

MutaGEL Parodontitis PCR Assay
MutaGEL Lactase PCR Assay
MutaGEL Collagen PCR Assay

EagleBio的iLite®分析就绪细胞iLite®  技术基于报告基因检测格式,经过修改和适用于整个药物开发周期中的应用以及生物药物的监测。这些细胞系可以开发用于任何生物制药靶标,并且可以使用相同的细胞系轻松设置药物效力(即药物活性)的测定方法。检验就绪的细胞经过基因工程处理,可与报告基因检验技术一起使用,以检测药物效力和NAb。